- Record: found
- Abstract: not found
- Article: not found
An open-label, multicenter, phase 1b study evaluating the safety and efficacy of CD40 agonistic monoclonal antibody APX005M and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.